GAMMA Investing »

Ngm Biopharmaceuticals shares owned by GAMMA Investing

Quarter-by-quarter ownership of Ngm Biopharmaceuticals (NGM) shares owned by GAMMA Investing from 13F filings

Historical chart of GAMMA Investing investment in Ngm Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ngm Biopharmaceuticals held by GAMMA Investing consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ngm Biopharmaceuticals by GAMMA Investing

Quarter filed Position value Share count Share price at filing
2024-03-31 $550 346 1.59
2023-12-31 $528 346 1.53

More positions owned by GAMMA Investing

Microsoft Corp Common Stock (MSFT)
Nvidia Corporation Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Jpmorgan Chase Common Stock (JPM)
Meta Platforms Inc Cl A Common Stock (META)
Alphabet Inc Cap Stk Cl A Common Stock (GOOGL)
Ishares Tr National Mun Etf Etf (MUB)
Visa Inc Com Cl A Common Stock (V)
Broadcom Common Stock (AVGO)
Alphabet Inc Cap Stk Cl C Common Stock (GOOG)
Ishares Inc Core Msci Emkt Etf (IEMG)
Eli Lilly Common Stock (LLY)
Home Depot Common Stock (HD)
Berkshire Hathaway Inc Del Cl B Common Stock (BRK.B)

View all positions for GAMMA Investing

Top funds holding Ngm Biopharmaceuticals

Column Group
BlackRock
Vanguard Group
StepStone
Euclidean Capital
Geode Capital Management
Trium Capital
ADAR1 Capital Management
Two Sigma Advisers
Northern Trust
Balyasny Asset Management
Federated Investors
Citadel Advisors
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Ngm Biopharmaceuticals